Teva intros generic Diclegis
Teva is introducing doxylamine succinate and pyridoxine hydrochloride delayed-release tablets in a dosage strength of 10/mg/10 mg.
The product is the generic of Duchesnay’s Diclegis (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets 10 mg/10 mg, and used to treat nausea and vomiting of pregnancy in women who have not improved with change in diet or other non-medicine treatments.
Teva’s product is available in bottles of 100.
No comments found